Arbutus Biopharma (ABUS) PT Raised to $5 at JMP Securities
Tweet
Share
E-mailGet Alerts ABUS Hot Sheet
Price: $4.67 +1.97%
Rating Summary:
7 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
7 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
JMP Securities analyst Roy Buchanan raised the price target on Arbutus Biopharma (NASDAQ: ABUS) to $5.00 (from $4.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- Arbutus Reports Second Quarter 2026 Financial Results and Provides Corporate Update
- Lithium Ionic Corp (LTH:CN) PT Lowered to Cdn$2.50 at Desjardins
- Tata Motors Passenger Vehicles (TMPV:IN) PT Raised to INR375 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
